AXON

Search documents
是时候利用 AppLovin 交易获得巨额年化收益了
美股研究社· 2025-07-10 12:39
未来几年,随着公司规模扩大,每股收益增速可能放缓,但营收增长会保持稳健。这种平衡意味 着市盈率等估值倍数不会受到太大影响。保守估计,一年后滚动 12 个月的市盈率在 42.5 倍左右 是合理的。如果届时公司滚动 12 个月的常态化每股收益能达到 12 美元,按这个市盈率算,股 价能到 510 美元。现在股价是 350 美元,也就是说,未来 12 个月可能有 45% 的上涨空间。 而且,考虑到动量因素和持续的业绩超预期,涨幅可能更大。最近几个季度,AppLovin 的财报 业绩都大幅超过市场共识预期,种种迹象表明这种情况会持续,估值倍数可能不降反升。只要业 绩能保持,市场情绪会越来越积极,股价涨幅可能超出当前合理预期。 公司的收入模式有部分是经常性的(基于使用量,不是订阅制),这种模式很稳健,现金流波动 小,所以股票收益也会比较稳定,容易吸引资金长期持有。 支撑公司现金流的是近 80% 的高毛利率,再加上低资本支出 —— 只要能摆脱目前影响其发展的 监管问题,它很有希望成为软件巨头。支撑这些现金流(杠杆自由现金流利润率 37%)的技术护 城河,是它的 AXON 平台。这个平台能提供 AI 驱动的实时广告竞价,依 ...
Prediction: After Datadog's S&P 500 Debut, These Stocks Could Be Next in Line
The Motley Fool· 2025-07-10 08:56
Being added to the S&P 500 is a big deal for any company, and usually a boon to its stock. Not only is the venerable large-cap index widely followed by individual investors, but many funds are built to replicate its performance, which results in consistent demand for its components as funds flow into those popular investment vehicles. It also means that whenever a new stock is chosen for inclusion, it tends to get a bump in its price as all of those funds must buy shares for their portfolios.Now, while the ...
Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic's AI Discovery Tools to Pursue New Drug Candidates
Globenewswire· 2025-07-09 12:00
REDWOOD CITY, Calif. and SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, and Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced a technology and research collaboration to pursue novel drug candidates using Iambic's leading AI models. In this ...
AppLovin's Strategic Shift Fuels Omnichannel Advertising Growth
ZACKS· 2025-07-08 15:46
Key Takeaways APP is shifting from mobile-first to omnichannel ads by expanding into CTV, web and e-commerce. The Wurl acquisition enhances APP's AI-driven monetization engine across new digital ad verticals. APP stock is up 46.5% in 3 months, outpacing the industry's 42.7% gain amid rising earnings estimates.AppLovin Corporation (APP) is accelerating its transformation from a mobile-first advertising platform into a diversified digital advertising powerhouse. At the heart of this evolution is a strategic ...
这家广告投放平台,为什么成为垄断市场的「千亿」鲶鱼?
36氪· 2025-07-08 13:30
可当你看到它的财报数据时,又会觉得这一切并非虚火:年利润超过40亿美元,净收入同比增长超过300%。在盈利能力面前,这家公司的股价表现反而显 得理所当然。 这家叫AppLovin的公司,不是我们熟悉的那种明星公司:没有轰动性的产品发布会,没有热搜上"炸裂""变天"的AI奇迹,也没有创始人一夜成名的神话。 但在全球广告市场上,它已是一台强悍且低调的盈利机器。 AppLovin没有做大模型,却凭借自研的广告引擎系统Axon,撑起了全球头部的移动广告投放平台。它不是内容平台,却比社交网络更懂用户偏好和行为; 它的客户不是C端用户,而是全球数百万App开发者和广告主;而它销售的,也不是流量,而是让每一分钱带来真实回报的能力。 相比在广告市场深耕的互联网巨头,AppLovin更像是一家深嵌系统、默默运转的商业基础设施:冷静的技术信仰、极致的工程执行,以及对广告系统中每 一个环节的持续更新,最后重构了广告主、开发者和平台之间的协作方式。 它的底色只有一句话:"Challenge the status quo。" 撕开裂缝: 为广告主构建信任的基石 在平台规则已经固化的行业里,"重写"能力是最稀缺的,也是最能改变行业身位的 ...
Buy 2 AI-Powered Technology Services Stocks to Tap Lucrative Upside
ZACKS· 2025-07-04 12:36
Industry Overview - The technology services industry is mature, with demand for services in good shape, and revenues, income, and cash flows are expected to gradually return to pre-pandemic levels, enabling stable dividends for most players [1] - The global shift toward digitization is creating opportunities in markets such as 5G, blockchain, and AI, with companies adopting generative AI, machine learning, and data science to gain competitive advantages [4] - The business software industry is benefiting from strong demand for multi-cloud-enabled software solutions as companies transition from legacy platforms to modern cloud-based infrastructure [4] Company Highlights AppLovin Corp. (APP) - AppLovin is a software-based platform for mobile app developers, enhancing marketing and monetization of apps [6] - The introduction of AI-powered AXON 2.0 technology and strategic expansion in gaming studios have significantly boosted revenue growth [7] - AppLovin's expected revenue and earnings growth rates for the current year are 16% and 84.8%, respectively, with a Zacks Consensus Estimate for current-year earnings improving by 0.1% in the last seven days [8] - The average short-term price target for AppLovin shares indicates a potential increase of 37% from the last closing price of $341.64, with a maximum upside of 90.3% [8] Duolingo Inc. (DUOL) - Duolingo operates as a mobile learning platform offering courses in 40 different languages and provides a digital language proficiency assessment exam [10] - The company utilizes AI applications to personalize and automate the learning process, with tools like Birdbrain analyzing real-time user performance [11] - Duolingo's expected revenue and earnings growth rates for the current year are 33.5% and 54.3%, respectively, with the Zacks Consensus Estimate for current-year earnings improving by 2.1% over the last 60 days [12] - The average short-term price target for Duolingo shares indicates a potential increase of 24% from the last closing price of $391.86, with a maximum upside of 53.1% [12]
X @Messari
Messari· 2025-07-03 18:03
RT Messari (@MessariCrypto)Messari shipped in Q2 🚢:- Messari Homepage- Project Pages- Mobile Upgrades- Stablecoin API- Networks API- Portals V2- New Taxonomy- Copilot V2- AI ToolkitFind all the data you need in one place at https://t.co/HZGfNqqQFg. https://t.co/EO1Nl63Cpq ...
X @Messari
Messari· 2025-07-02 18:18
Messari shipped in Q2 🚢:- Messari Homepage- Project Pages- Mobile Upgrades- Stablecoin API- Networks API- Portals V2- New Taxonomy- Copilot V2- AI ToolkitFind all the data you need in one place at https://t.co/HZGfNqqQFg. https://t.co/EO1Nl63Cpq ...
Revolution Medicines and Summit Therapeutics Enter into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors with Ivonescimab in RAS Mutant Tumors
Globenewswire· 2025-06-30 12:00
REDWOOD CITY, Calif. and MIAMI, June 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS- addicted cancers and Summit Therapeutics, Inc. (Nasdaq: SMMT), a biopharmaceutical oncology company focused on patient-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs, today announced the companies have entered into ...
计算机行业2025年中期投资策略:AI及无人化聚焦落地,重视稳定币及RWA金融创新
CMS· 2025-06-30 10:56
证券研究报告 | 行业策略报告 2025 年 06 月 30 日 AI 及无人化聚焦落地,重视稳定币及 RWA 金融创新 计算机行业 2025 年中期投资策略 TMT 及中小盘/计算机 回顾 25 年上半年计算机板块行情,AI、金融科技创新、无人化三大主线轮动。 我们再次重申,科技创新是 25 年增长主线,重点关注 AI 迭代创新及 AI 算力、 金融科技创新、机器人场景落地等方向投资机会。 推荐(维持) 行业规模 | | | 占比% | | --- | --- | --- | | 股票家数(只) | 284 | 5.5 | | 总市值(十亿元) | 3525.2 | 4.0 | | 流通市值(十亿元) | 3104.0 | 3.9 | 行业指数 % 1m 6m 12m 绝对表现 8.9 9.3 61.3 相对表现 6.8 10.7 47.8 资料来源:公司数据、招商证券 -20 0 20 40 60 80 100 Jul/24 Oct/24 Feb/25 Jun/25 (%) 计算机 沪深300 相关报告 1、《香港虚拟资产服务相关牌照梳理 — — 计算机周观察 20250629 》 2025-06-29 ...